Clinical Trial: Cytokines and Chemokines in Erythema Migrans
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Inflammatory Proteins, Gene Polymorphisms, and Transcriptome Profiles in Patients With Erythema Migrans
Brief Summary: The main objective of this study is to characterize the inflammatory proteins, gene polymorphisms, and transcriptome profiles in patients with erythema migrans to gain better insight into pathogenesis of early Lyme borreliosis and to define new immune modulators that could serve as biomarkers of disease activity.
Detailed Summary:
Sponsor: University Medical Centre Ljubljana
Current Primary Outcome: inflammatory proteins in erythema migrans patients [ Time Frame: up to 12 months follow-up ]
Original Primary Outcome: Same as current
Current Secondary Outcome: gene polymorphisms in erythema migrans patients [ Time Frame: at enrollment ]
Original Secondary Outcome: Same as current
Information By: University Medical Centre Ljubljana
Dates:
Date Received: June 24, 2013
Date Started: July 2013
Date Completion:
Last Updated: May 4, 2017
Last Verified: May 2017